Samit Hirawat, EVP, Chief Med.Offr, Drug Development at BRISTOL MYERS SQUIBB CO (BMY), bought 4,250 shares at $47.58 ($202K) on 2025-04-25, disclosed to the SEC on 2025-04-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |